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Participation in the BioResource: Biobanking and value in the changing NHS 
Abstract 
The National Institute for Health Research BioResource is not a typical biobank.  It 
banks biological samples and other data, but also volunteer commitment to 
potential future research participation.  Researchers can then, using the 
BioResource as an intermediary, invite volunteers who meet specific genotypic or 
phenotypic criteria to participate in studies.  Using participant observation and 
semi-structured interviews with those involved in recruiting new and engaging 
existing volunteers, this paper explores how participation is understood and 
cultivated, and how (bio)value is produced in routine BioResource work.  We 
contribute insights into a different configuration of biosocial participation where the 
engaged individual, as opposed to biological sample, is the site of value.  
Foregrounding the often ignored work of biobank staff, we demonstrate the 
iterative and reflexive way value is created and maintained through staff activity, and 
the different way actors make sense of the site and stability of this value. 
 
1 Introduction 
Rushing down a long, sanitised, hospital corridor on my way to a meeting, I hear my 
shoes clatter on the hard, vinyl floor.  Clinical staff in their colourful uniforms and 
rubber shoes glide with purpose towards me while other bodies look lost, eyes 
searching the corridor for signs to direct them.  As I move further down the chair 
lined passage, I encounter three members of hospital staff at a table, trying to make 
eye contact with those who pass by.  Their table is laden with leaflets, clipboards, 
mugs, pens and, most distinctly, a large model of a double helix.  A banner tells me 
that “Research Needs You.”  At first glance, it appears to be a fundraising exercise, 
typical of the English hospital.  However, this is something different.  As I quickly 
pass by the stall, an individual is sat completing a form while another approaches 
the table, asks about the double helix model and, for the few seconds, I hear 
snippets of information about genetics and health research.  This was my first 
encounter with the BioResource.  (David Wyatt). 
The BioResource, discussed in this paper, is part of wider transformations in the National Health 
Service of England (NHS).  Since the publication of Best research for best health: A new national health 
strategy (Department of Health 2006), the NHS has embarked on a process where its focus is not only 
on the provision of universal health care to the population but also on positioning itself at the forefront 
of medical research.  One of the ways the Department of Health pursued this vision was by establishing 
the National Institute for Health Research (NIHR) (ibid.).  The NIHR presents itself as “the most 
integrated clinical research system in the world” and claims to “drive research from bench to bedside 
for the benefit of patients and the economy” (https://www.nihr.ac.uk/about-us/our-purpose/).  It aims 
to do this by funding research projects, supporting the training and development of researchers, 
working with industry, and providing research facilities and infrastructures.  The BioResource discussed 
in this paper is one of these research infrastructures. 
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In 2005, through a collaboration between the University of Cambridge and the Medical 
Research Council Epidemiology Unit, a BioResource was established in Cambridge.  Building on this 
BioResource’s perceived success, the NIHR funded its expansion.  NIHR BioResource is now constituted 
by a federation of thirteen independent BioResources across England.  These BioResources work 
independently and together to streamline and support the recruitment of research participants for 
specific studies.  BioResource staff recruit volunteers, with or without existing health conditions, who 
are willing to take part in future research studies.  To join the BioResource volunteers provide biological 
samples containing genetic information, lifestyle and health information and, for those with existing 
health conditions, access to their clinical records.  Healthcare professionals, academics and members of 
the commercial pharmaceutical industry can then apply to the BioResource to identify volunteers that 
meet specific genotypic and/or phenotypic criteria and invite them to take part in new studies.  The 
details of those willing to participate in the specific study are then passed to the researcher to contact 
directly. 
David’s initial exposure to the BioResource, recounted above, affords an insight into some of 
the routine practices of BioResource recruitment.  Drawing on findings from ethnographic observation 
of the day-to-day work of a BioResource and semi-structured interviews with its staff, we explore how 
BioResource participation is performed, understood and configured.  We examine the labour of running 
this biobank and focus on the mundane and often invisible work involved in facilitating participation in 
the BioResource and the production of value.  Existing accounts of (bio)value in biobanking situate value 
in biological fragments (for example, blood or tissue samples), and the potential these fragments offer 
for medical innovation and research.  We contend that the BioResource represents a distinct form of 
biosocial participation where its value is the engaged volunteer (as opposed to their partible samples 
and associated data) and this value is the product of the labour of both volunteers and BioResource 
staff.   Value in this context is not fixed, inevitable or linked to the market but produced and maintained 
through the structured activities of the BioResource and ongoing engagement of volunteers.  Our 
account suggests existing concepts of clinical labour and biovalue are insufficient in conceptualising and 
encapsulating all the work involved in producing value. 
2 Biobank participation, biobank labour and biovalue 
In his influential study of blood donation, Titmuss (1970) examines two different ways of 
developing a supply of blood for transfusions post World War II.  While the United States offered 
payment for blood, Titmuss found that in the UK a better quality and quantity of blood was achieved 
through a system of donating for no financial reward.  Titmuss claims this is a gift relationship and the 
act of giving blood contributes to the social good and creates ties between individuals, establishing 
communities.  Titmuss’ account infers a hierarchy of participation, with gift donation held firmly aloft 
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of commodity purchase.  Others have highlighted that the divide between gift and commodity is neither 
static nor mutually exclusive (Frow 1997; Harris, et al. 2013; Lipworth, et al. 2011; Waldby and Mitchell 
2006) and have questioned the compatibility between Titmuss’ ‘gift’ and Mauss’ account of gift 
exchange (Tutton 2002), Yet, Titmuss’ work remains important today, providing a compelling argument 
in support of the welfare state (Frow 1997) and embedded in public guidelines, such as the UK Medical 
Research Council’s 2001 Human Tissue and Biological Samples for Use in Research (Tutton 2002). 
For Titmuss, altruism was a central feature of the rationale to give blood.  While altruism 
dominates clinical researchers’ understandings of participation (Adams and McKevitt 2015), in research 
and biobank participation there is an acknowledgement of a more complex set of rationales (Adams 
and McKevitt 2015; Tutton 2007).  For example, in the Swedish context, Hoeyer (2006) foregrounds the 
issues of trust in the organisation and notions of fairness, (see also Cool (2016) and, in the Norwegian 
context, Steinsbekk et al. (2013)).  Hoeyer (2006, 791) reports that some experienced participation as 
“taking part in a shared welfare state project.”  In the NHS, participation in research has been framed in 
a similar way: healthcare is provided, and in return, citizens have a responsibility (or at least are 
expected) to “give back” by participating in research as a moral duty, civic virtue, matter of citizenship 
(Chadwick and Berg 2001; Mitchell 2012; Woolley, et al. 2016) or even as an entitlement – patients have 
a right to be aware of opportunities to participate in research (Adams and McKevitt 2015; Wienroth, et 
al. 2018). 
Tutton’s (2007) focus group study on biobank participation adds texture to our understanding 
of what counts as participation and how this term can be operationalised instrumentally by institutions.  
“Participation” is often used to infer a democratic process linked to notions of public involvement or 
‘active citizenship’, said to “emphasise people’s rights (and duties) to participate in decision-making 
processes (Marinetto 2003, Turner 2001)” (Tutton 2007, 174).  Such accounts present citizens as 
informed, engaged and knowledgeable.  In practice, however, participation rarely provides space for 
citizens to enact these qualities (Tutton 2007).  Instead, it often entails the provision of samples, the 
completion of forms and the ad hoc receipt of news from the biobank about recent research.  Viewing 
citizens as informed, astute, and able to make free, rational choices is the cornerstone of contemporary 
informed consent (Corrigan 2004).  Yet even this is complicated further by biobank participation, as 
being able to define how data will be used in advance is not always possible (Shickle 2006; Tutton and 
Prainsack 2011) and the right to withdraw is difficult to facilitate (Melham, et al. 2014). 
In the UK the most prominent biobank is the non-profit, publicly funded charitable company, 
UK Biobank.  Having collected samples, lifestyle information and established links to the “cradle-to-
grave” NHS health records of 500,000 volunteers, it is lauded as “a major national and international 
health resource” and claims that, “over many years […] will build into a powerful resource to help 
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scientists discover why some people develop particular diseases and others do not” (UK Biobank n.d).  
Tutton and Prainsack (2011) suggest that UK Biobank utilises a notion of ‘public good’ and report that it 
promotes a particular kind of subjectivity in its participants, that of the “altruistic self.”   The altruistic 
self “is addressed through a discourse of communitarianism, and […] enrols in the biobank, freely giving 
of themselves with no expectation of anything in return” (Tutton and Prainsack 2011, 1090).  Busby and 
Martin (2006) frame participation in UK Biobank slightly differently.  Rather than altruism specifically, 
public good is operationalised in terms of British identity, community, the benefits for the country now 
and for future generations.  Across both accounts, participation in research with the potential to benefit 
the wider community is, at least in part, expected. 
The NIHR BioResource has many similarities with UK Biobank but differs in some noteworthy 
respects.  Whereas UK Biobank is supported by but situated outside of the NHS and NIHR, the 
BioResource is funded through the NIHR and thus the NHS.  While both occupy a landscape where in 
the last twenty years the UK government has set ambitions on utilising the life sciences industry to 
invigorate the economy and develop its competitiveness on the international markets, the NHS context 
of the BioResource is significant for how we understand participation.  With the publication of Best 
research for best health: A new national health strategy (Department of Health 2006) and numerous 
initiatives (including establishing the NIHR), the NHS situates research and support for research not as 
peripheral to its jurisdiction but embedded at the heart of its work.  Though for some time there has 
been an expectation that patients are willing to participate both in defining research priorities and in 
health research, it was only in the NIHR (2015) publication, Going the extra mile, that participation in 
health research was framed not as an altruistic act but as a patient duty.  This shift to develop a “research 
culture” in the routine functions of care provision (Malby and Hamer 2016) and transform the NHS into 
a research leader, reframes the relationship between citizen and state: universal healthcare is provided 
as a right (and from taxpayers’ money), but citizens also have a duty to participate in research and, by 
extension, contribute to the health of the wider population and the wealth of the nation through the 
bioeconomy. 
The biobanks also differ in how they can be used for research.  UK Biobank records remain viable 
research data unless the individual withdraws consent.  BioResource records can only be used by 
BioResource staff to identify and contact those who meet the specific genotypic and/or phenotypic 
criteria required for a research study.  UK Biobank has the ability to re-contact participants too, but this 
is a secondary function.  For the BioResource, this is its only function.  It is dependent on volunteers 
enacting their supposed duty to participate in research when invited and researchers opting to utilise 
the BioResource in identifying eligible research participants. 
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The specific NHS/NIHR and English socio-historical contexts foreground a convergence of 
biotechnology and capital production in what was previously a site of solely healthcare provision.  This 
“implosion of capitalism with ‘life itself’”, referred to by Sunder Rajan (2006, 171) as biocapital, brings 
into focus questions about how value is created, how it circulates and to whose benefit.  We focus on 
the first of these points in our analysis, exploring how BioResource value is constructed, understood and 
reinforced in the practices of BioResource staff. 
To understand value, we first draw on Waldby’s concept of biovalue to emphasise the potential 
offered by the collection and use of biological fragments in the bioeconomy.  Defined as “the yield of 
vitality produced by the biotechnological reformulation of living processes” (Waldby 2002, 310), 
biovalue is not rooted in an inherent property of biological material.  Instead, it is realised in market 
exchange or in its potential to improve the health of the population.  While in this initial conception, 
the fragment is divorced from the individual who donated it, in the context of biobanks, this continued 
link between individual and biological sample can be an important part of biobank biovalue (Mitchell 
and Waldby 2010).  For example, access to an individual’s ongoing medical records provides more data 
and context to any biological samples held and may offer a greater potential for biomedical research. 
We believe biovalue is useful in foregrounding the often explicit promise of biotechnology and 
the bioeconomy, but also in demonstrating the process of actively producing and nurturing value that 
we argue takes place through the work of BioResource staff.  It is, however, limited through its 
conception of biovalue as a commodity rather than an asset.  This point is stressed by Birch and Tyfield 
(2013) who suggest that viewing biovalue as a commodity forces us to see biovalue as situated in market 
exchange.  In market logic, increased supply should decrease value.  Viewing biovalue as an asset, Birch 
and Tyfield (2013) argue, allows for tangible and intangible artefacts to have some value independent 
of the market.  It also allows for the accumulation of artefacts as a means of increasing value. 
In our case study, this distinction is important, particularly when one sees the emphasis some 
actors placed on accumulating new volunteers as a means of increasing the size and, by extension, the 
perceived value of the BioResource.  As such, we avoid using Waldby’s term, biovalue, in the following 
sections, adopting ‘value’ instead.  The value of the BioResource is, however, neither fixed nor 
consistently understood by different actors.  We argue that it is through an attention to the labour of 
both volunteers and BioResource staff in rendering the BioResource of value to biomedical research 
that we see processes of creating and maintain value that are both iterative and ongoing.  Clinical labour, 
introduced by Mitchell and Waldby (2010) and developed by Cooper and Waldby (2014), encapsulates 
the embodied actions completed by volunteers in participating in research.  Ranging from allowing their 
blood to be drawn and used in research, through to surrogacy, clinical labour foregrounds the work 
involved in and expected of participants giving access to in vitro biology for research and, by extension, 
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aids in the creation of value.  It does not, however, allow us to consider all of the different forms of 
labour involved in value production.    
In their examination of 23andMe, Harris et al. (2013) separate the clinical labour of providing a 
saliva sample and completing initial paperwork involved in purchasing the direct to consumer genetic 
testing services, from the ongoing ‘free labour’ (Terranova 2000) involved in participating in 23andMe’s 
research arm.  The transfer of the genetic test data paid for by the consumer to the research arm of 
23andMe is presented as a gift, donated by the consumer for the purposes of research.  The consumer 
is then inducted into a community of other donors and invited to complete further acts of free labour 
such as the completion of online health questionnaires, participating in online fora and taking part in 
research studies.  Entry into this research community promotes sociality and is framed as altruism.  
Harris et al. (2013) argue that this distracts consumers from the free nature of their labour in the process 
of generating economic value for 23andMe.   
23andMe differs from the BioResource in some respects, particularly as the 23andMe research 
database has value independent of the additional free labour completed by the community of 
volunteers.  Once donated, the data obtained through genetic tests can be mined, aggregated and used 
in research.  Its value, although enhanced by additional information from the community of volunteers, 
is not predicated on this additional volunteer work.  It does, nonetheless, help us see clinical labour as 
just one form of labour at play in the production and enhancement of value.  Our study extends this 
point further to highlight the limits of associating clinical labour straightforwardly with (bio)value 
production, the already held samples and other data as consistently sites of value, and the isolated (or 
collective) participant as an unmediated asset.  In fact, our analysis highlights how the routine work of 
BioResource staff in not only accumulating new volunteers but in maintaining an engaged cohort of 
willing, stratifiable volunteers for future research is iteratively and practically accomplished in the 
everyday work of the biobank and how this contributes to the BioResource’s value.  Such work includes 
the labour involved in the recruitment process, negotiating recruitment sites, the maintenance of the 
database and on-going engagement work.  We contend that by looking at the labour involved in the 
formation, recruitment, engagement and participation in the BioResource, we are able to see a 
particular form of biobank where value is not situated solely in samples or links to individuals, or in its 
potential for research or market exchange, but in ongoing, biosocial participation by the engaged 
volunteer.  While biosocial participation here does not neatly reflect more established kinds of groupings 
presented by Novas (2006) in his work on patient groups, the BioResource does, nonetheless, present 
a case where new groupings of biologically knowable volunteers are being formed and used for 
knowledge production.  The BioResource is predicated on individuals acknowledging the importance 
and potential of biology, in particular genetics, in health research and believing they have a role to play 
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in this research.  However, in the case of the BioResource, as framed above and below, there is also a 
duty to participate; the BioResource produces “experimental subjects” (Sunder Rajan 2008) from the 
citizenry at large.  Our focus here however is on how participation in the BioResource, along with the 
mundane, everyday work of BioResource staff, facilitates value and extends our understanding of the 
labours involved in this production process. 
3 Methods 
The BioResource where this research took place is located in one of the NHS Trusts in London, 
England, where four of the thirteen infrastructures are based.  Data was collected over a ten-month 
period.  Interested in the mundane work of BioResource biobanking, we spent one day a week observing 
the everyday activities of the BioResource, including recruitment and office work.  We attended weekly 
team meetings, one national BioResource coordinators’ meeting and monthly management meetings 
within the NHS Trust.  We conducted semi-structured interviews with seven of the eleven individuals 
employed by the NHS to work for the BioResource during the research period.  Three members of staff, 
including the previous BioResource Manager, and two research assistants, left before the interviews 
took place.  Of these three, only the manager was replaced.  The other individual, the clinical nurse, 
declined to participate in an interview, giving no reason, but agreed to be observed.  Interviews lasted 
on average 43 minutes.  Despite having different roles, for example, laboratory technician or 
BioResource manager, all staff were involved in active recruitment.  Interviews focused on their everyday 
work activities including the recruitment process, interactions with current BioResource volunteers and 
other BioResources and the interviewee’s understanding of the role and function of the BioResource.  
These were recorded and transcribed verbatim.  All resulting data was open-coded and analysed 
thematically (Miles and Huberman 1994).  Codes were discussed with and agreed by all authors.  In the 
following sections, we explore the everyday realities of doing BioResource work.  Unless otherwise 
stated, we use “BioResource” to refer to our specific BioResource research site and not the overarching 
federation of thirteen locations. 
To maintain the anonymity of the research participants, pseudonyms have been used 
throughout. 
4 Forming the BioResource 
The BioResource was established in 2014 with the target to recruit 10,000 volunteers in a two-
year period.  To meet this ambitious goal, the BioResource initially employed six members of staff - a 
manager, a clinical nurse, a research assistant, an administrator, a database coordinator and a laboratory 
technician.  All staff were trained in the recruitment process, but only the research assistants and clinical 
nurse were able to take blood samples from volunteers.  When not contributing to recruitment work, 
the other staff supported the BioResource by processing samples, managing data, reporting to 
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management and organising the everyday activities of the BioResource.  During our fieldwork, staff 
numbers fluctuated due to staff attrition and the employment of additional research assistants. 
Staff numbers and structures differed between the local BioResources.  This was particularly 
evident when we attended a National BioResource meeting.  Some had small teams but partnerships 
with other organisations.  Others had large teams who not only recruit for the BioResource but other 
projects too.  While the overall aim of recruiting volunteers to join the BioResource was consistent 
across different BioResources, recruitment strategies and practices were dictated by local NHS Trust 
managers, a point returned to in the next section.  
Interested in the development of the BioResource at a local level, we pursued the process of 
setting up the BioResource with James, the database coordinator and the only member of staff who had 
worked at the BioResource from its inception.  His initial task was to build from scratch the database 
that houses all volunteer information and draft the data procedures for staff.  He was supported in this 
process through three monthly meetings with other data coordinators.  However, there was no common 
database framework from which to start.  The disconnect between national infrastructure and local 
practice from the very beginning, particularly the lack of a common database, was not lost on James, 
especially now that local BioResources are trying to integrate datasets, as he explained: 
We've encountered some issues. I mean, the whole purpose of the BioResource in 
the first place was to have a national database. 100,000 people in the database[. ..]  
The first years it was 10,000 patients [per local BioResource,] then it was going to 
be merged into sort of a national database. The issues [we]'ve been hitting are 
merging each local BioResource’s database into a national one.  We haven't got 
there yet.  We’re still working on it but there’s obviously lots of issues involved with 
data types and [getting] everybody working from the same page because there’s 
not a centralised [system].  [..I]t’s not been organised from the top, it’s been very 
federalised.  Each BioResource is working to their own standards and things, so 
that’s been an issue where when you want to actually merge it together. 
This image of the National BioResource, developing from the bottom up in a “federalised” way 
with different local database systems, contrasts with more sophisticated biobanks like UK Biobank and 
23andMe.  Mapping fields between databases, streamlining recording and coding practices are all 
necessary prerequisites for an integrated and efficient system.  James’s acknowledgement that the 
merge of records was not to take place until the “10,000 patients” target was met infers a priority for 
recruiting volunteers over other aspects of work.  This is reflected in our experiences in the field and 
represents an important point of disjuncture in understandings of the site and stability of value.  We 
explore these themes in the next two sections. 
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5 Recruiting BioResource volunteers 
The BioResource’s initial recruitment strategy targeted outpatient clinic attendees.  
BioResource staff trained clinic staff (clinical nurses and phlebotomists) to recruit for the BioResource 
as part of the patient’s visit to the hospital.  Fitting into wider imperatives to support and facilitate 
research within the NHS, as discussed earlier, the BioResource attempted to situate itself within such a 
narrative where recruitment activity is part of routine hospital work.  With the paperwork completed 
and blood or saliva samples obtained by clinic staff, the BioResource team would then process this 
information.  This approach to recruitment, however, proved difficult.  An unpublished BioResource 
report on barriers to recruitment stated that clinical staff did “not recognise [BioResource recruitment] 
as part of their routine duties”, despite the national drive for research and this project taking place in a 
research-intensive hospital.  This report also stressed that clinical staff see “no evidence of benefits for 
their careers” by contributing to BioResource recruitment work and that the “relevant 
managers/Principal Investigators do not ensure recruitment is happening.”  Equally pressing were the 
“staffing issues and busy clinical workload” that prevent the undertaking of additional work.  These 
barriers were reflected in informal conversations with the BioResource staff.  Completing recruitment 
in this way not only relied on clinic attendees being receptive and willing to join the BioResource, but 
on clinical staff seeing research work as a crucial and routine part of their everyday work.  This account 
speaks to a broader disconnect between the stretched healthcare workloads of hospital staff and the 
vision of a research-led NHS where research is embedded in everyday practice. 
With a target of recruiting 10,000 volunteers, pressure to increase BioResource volunteer 
numbers was high.  Local hospital management meetings often involved discussion of recruitment 
numbers and targets.  Jennifer, the former BioResource Manager provided some context to this focus 
on numbers.  She explained that participant recruitment is important in the research function of the 
hospital.  Recruitment data is tracked and has implications for the NHS Trust and its future NIHR funding.  
As such, the accumulation of BioResource volunteers received significant attention.  With the limited 
success of recruitment in outpatient clinics, senior NHS managers suggested a more direct method - 
weekly stalls in public spaces at the different hospital sites (Unpublished BioResource Recruitment 
Strategy, 2015a).  Approved by the hospital Trust, and enacted by Jennifer and her team, the adoption 
of this method not only asserted the importance of research to the hospital but presented communal 
hospital spaces as legitimate sites for research recruitment work.  It transferred the responsibility and 
enactment of recruitment work from clinicians to BioResource staff and provided the BioResource with 
access to those visiting the hospital, not just those attending appointments.  To support this greater 
focus on active recruitment work, two additional research assistants were employed.  Figure 1 shows 
recruitment data for the BioResource.  The adoption of stall-based recruitment occurred at Month 10, 
demonstrating the substantial increase in volunteer numbers this approach generated. 
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Figure 1 BioResource recruitment data (Unpublished BioResource Recruitment Strategy, 2015b). 
When our fieldwork commenced, these stalls were embedded in routine recruitment work, and 
staff had developed strategies to perform recruitment in this public setting.  Sitting in a weekly 
BioResource staff meeting early in our research, we observed some of the mundane discussions and 
decisions that take place in facilitating this type of recruitment.  They decided who would attend each 
of the hospital sites the following week and on which days, the recruitment targets by site and by day, 
and when couriers would be required to move blood samples to the laboratory site.  News was shared 
about the previous week’s recruitment figures and a recent senior management meeting.  At the end 
of this meeting, interested in how the stall recruitment process works in practice, we asked how they 
recruit in these public spaces.  The BioResource staff’s responses reflect David’s experience, reported 
in the introduction.  Stressing that they do not actively approach individuals, they reported that they 
use “the stand”, “banners”, “put catchy stuff on the table” and “offer mugs”, all to attract the attention 
of those on the corridor.  In an interview with Matt, a Laboratory Technician we probed further: 
Normally we would have something, I don’t know, fun maybe on our table. We might 
have a model of DNA or something and you would just make a remark about that 
maybe and try and engage them in a little bit of light conversation.  Then introduce 
the thought of ‘do you want to actually partake in some medical research?’  I mean 
for people who actually go on the stall regularly I think it’s quite hard to be 
motivated and keep repeating the same [thing].. 
These stalls were set up for five hour periods with up to three BioResource staff members there 
at a time.  Matt’s account presents an ideal situation where the potential volunteer approaches the 
table and then he can start speaking to them and introduce the BioResource.  However, the need for 
substantial motivation, repetition and the location in busy public spaces, imply the difficulty of this work.  
The generally polite hospital visitors were often either unwilling to participate or unwilling to commit to 
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the twenty minutes necessary to complete the relevant forms and provide a blood sample.  While this 
recruitment site was more fruitful than the clinic, a good day still only resulted in ten new volunteers 
against their 10,000 volunteer target. 
These stands present a particular vision of participation and the BioResource.  With a model of 
the double helix representing “science” and a leaflet and banner both proclaiming “Research Needs 
You”, reminiscent of the British 1914 wartime call to arms, “Your Country Needs You”, participation in 
scientific advancement is presented as a collective, national duty.  While this rhetoric is in line with 
Going the extra mile, mentioned above, it differs from the motives reported by staff through their 
interactions with volunteers.  They reported volunteers emphasising “giving back” to the community or 
to the hospital for the care they received, having an illness themselves or having family or friends with 
an illness and wanting to help future research.  While altruism is a convenient framework in which to 
understand volunteer action, as mentioned above, rationales for health research participation focusing 
on altruism alone oversimplify a complex array of motives.  Nonetheless, these motives, however 
compelling, did not result in huge jumps towards the 10,000 volunteer target.  Furthermore, the 
practice of using public spaces for this recruitment, such as hospital corridors raised some concerns for 
staff:  
I don't particularly like the stall that much because for me, personally, if I were 
walking down a corridor, and it’s a busy corridor, and somebody stopped me and I 
have to fill out information that might require disclosing my medical condition, I 
wouldn't feel comfortable doing it in an open space (Claire, Research Assistant). 
Despite airing this unease, practice did not change and corridor recruitment remained the main 
recruitment strategy.  In authorising this work to take place in the corridor at an institutional level, the 
push to increase the number of volunteers trumps the ethical concern of privacy, raised by Claire.  Our 
observations of everyday work and NHS management meetings reinforce this focus on increasing 
volunteer numbers.  Numerous line graphs were projected on walls and distributed in handouts.  Tables 
breaking down recruitment by hospital site and clinic were discussed and unpicked.  Upward trends, 
such as that presented in Figure 1, were used as markers of success, milestones were celebrated with 
cakes for the BioResource staff, from the first volunteer to the x thousandth.  This association between 
the accumulation of volunteers and ideas of success was also present in numerous pieces of formal 
documentation (Recruitment Strategies and management reports), information presented at National 
BioResource meetings and in weekly team meetings, where recruitment statistics and targets formed a 
staple component.  The focus on increasing numbers presents the value of the BioResource and its 
potential to contribute to the bioeconomy as situated firmly in the one-time clinical labour of volunteers 
joining the BioResource.  This is an asset to be accumulated and is the central focus of the BioResource. 
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Even when acknowledging the ongoing relationship with volunteers necessary for the 
BioResource to function as a broker of research participants, participation in later research is either 
assumed or ignored.  Such an approach is consistent with the assumption that participation in research 
is a duty but is not reflected in the laborious process of recruiting small numbers across extended 
periods of time.  BioResource staff, however, acknowledged more is necessary to transform this closed 
repository into a useful and valuable resource in the research process – as Claire notes, “…even though 
they've said yes, you can't really do anything with the sample unless you contact them a second time 
and they say it's OK.”  As Claire recognises, recruiting a volunteer to the BioResource is just the first step 
in contributing to future research.  Aware of the importance of volunteers remaining open to 
participating in future research through the BioResource, staff discussed the need to do something to 
develop and nurture a longer-term relationship with volunteers.  Looking to the original BioResource in 
Cambridge as an example of success in this type of biobanking, the BioResource staff noted how 
Cambridge incorporated engagement activity into their routine practices.  With this precedent, and staff 
agreement, Jennifer decided they should also complete some engagement work with BioResource 
volunteers. 
6 Engaging BioResource volunteers 
Sat around a table scattered with pens, paper, plates of biscuits and mugs of steaming coffee, 
BioResource staff discussed what they could do to enhance and develop a relationship with BioResource 
volunteers.  They had many ideas - from newsletters to performance art, social media platforms  to 
public debates.  While some ideas were already used by other BioResources, such as social media 
platforms, these were not viable options for the BioResource as they did not have the capacity to run 
social media accounts and maintain their recruitment activity without increasing staffing.  This limited 
the type and extent of engagement activity the BioResource could commit to.  They focused on on-
going engagement activities as opposed to a one-off effort.  Equipped with a small budget from the 
BioResource’s own funds, limited staff time and guided by Cambridge who also use this method, they 
decided to produce a biannual newsletter for all volunteers.  
The resulting newsletter, completed over an eight-month period, went through six substantive 
versions.  BioResource staff sketched infographics; decided on exact content; drafted, redrafted and 
edited text; calculated postage costs; and arranged a platform to host and monitor the electronic 
version of the newsletter.  The content provided updates on the BioResource - details of the recruitment 
figures and news on the BioResource team.  The BioResource was situated in the context of the National 
BioResource and readers were told about the process of collecting and storing volunteer samples, data 
and the potential use of this data.  The newsletter also provided accounts from volunteers, describing 
their experiences of joining the BioResource and the positive benefits of health research.  BioResource 
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staff had hoped to include examples of how the BioResource itself has contributed to medical research 
but as it was relatively recently established this was not possible. 
The resulting newsletter did have an effect, as Helen the BioResource Manager highlights: 
When we sent our recent newsletter out, people were keenly replying saying ‘you 
haven't contacted me yet, do you want me?’.  They're so keen to be involved, which 
is really good when you think about it because the first lot were emailed out and, 
you're a busy person too, not everybody looks at their emails religiously.  It’s good 
that people are responding positively and clicking through. 
Luke, the Database Administrator, expanded further on these interactions sparked by the 
newsletter: 
We sent out some newsletters recently and we are getting responses back, so I had 
to reply to these people, lots of them.  […S]ome wanted to join the BioResource as 
well, having heard about it from family.   
We got some [responses] where people were very happy to receive the newsletters 
and to know that they are really contributing, assisting the BioResource.  Some 
wanted to know if there are studies which they can participate in.  They were really 
willing.   
Luke and Helen’s accounts present an encouraging response to the newsletter.  The newsletter 
served to inform and generated interaction from some volunteers.  It also resulted in the recruitment 
of new volunteers through introductions from the existing cohort.  Luke’s account reflects this positivity.  
Responses such as these led the BioResource to judge the newsletter a success.  This success was 
particularly focused on its role in creating dialogue between the BioResource staff and volunteers.  Staff 
saw it as a way of reminding volunteers of the BioResource and, by extension, the need to keep contact 
details up to date and maintain willingness to participate in research.  The newsletter became part of 
an active process of maintaining and nurturing the utility of the BioResource.  These activities and the 
perceived need to sustain long-term engagement with volunteers present the BioResource as not 
constituted by the properties of the database entries and samples, but by individuals and their labour.   
7 Discussion 
We have explored how participation in the BioResource is understood by different actors and how 
this relates to understandings of the site and stability of its (bio)value.  Drawing on ethnographic data 
we document some of the mundane aspects of BioResource work, from recruitment activity through to 
engagement, along with local and institutional drivers for how these activities are configured.  
Embedded in these drivers are different understandings of the value of the BioResource.  At an 
institutional level, the BioResource is understood as something with a tangible, stable and material 
value; it is not contingent on further activity.  Graphs plotting upward trends in recruitment numbers 
are viewed as symbols of success.  In this conception, database entries are the asset viewed as of value 
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to the bioeconomy.  The institutional understanding conforms to an audit culture where success is 
measured within the NHS Trust and more broadly by the NIHR through simple metrics.  The need to 
demonstrate consistently increasing volunteer numbers was instilled further by the suggestion, 
approval and adoption of recruitment in hospital corridors and the provision of dedicated staff for such 
work.  These stalls also present a visible shift in the nature of the hospital, signalling that public spaces 
within this typical care site are now legitimate sites for recruitment and research work. 
Viewing the value of the BioResource as material, the institutional understanding does little to 
acknowledge that volunteers have not agreed to participate in research studies by joining the biobank.  
Instead, it follows the logic pressed by the NIHR in Going the extra mile that research participation is a 
duty and, thus, participation can be assumed.  In this configuration, it is not altruism (Titmuss 1970) or 
an imagined community alone (Busby and Martin 2006), but an obligation between citizen and state.  
While we did not include interviews with volunteers in our data collection, the practices of recruitment 
and the reported volunteer motives for participation suggest a more complex picture.  The recruitment 
labour of the BioResource staff does not result in large, new volunteer numbers  - on a good day, five 
hours spent on a recruitment stall results in just 10 new volunteers and numerous rejections.  Citizens 
do not appear to rush or feel compelled to participate, at a general level, to “give back”. 
Whereas at an institutional level increasing volunteer numbers is the focus of the BioResource, 
its staff acknowledge the importance of also maintaining the existing cohort’s willingness to participate 
and, in doing so, draw on a more granular understanding of the BioResource as a broker of research 
participants.  Biosocial participation in this context is ongoing, long-term and not to be assumed.  It is 
through our attention to the everyday practices, and the labour involved in BioResource participation, 
that this disconnect between institutional and local understandings of value and participation is brought 
into stark relief.  In particular, our case study of staff demonstrates the importance of not only 
considering value, but the varying ways it is assumed, produced and maintained, by different actors.  In 
the context of everyday practice, this occurs through the ongoing labour of BioResource staff and 
volunteers.  The activity of recruiting new volunteers (often absent in other studies) and engagement 
work of BioResource staff help to target and sustain engagement.  A volunteer’s clinical labour in joining 
the BioResource and their free labour (albeit less sophisticated than that envisaged by Terranova (2000) 
or highlighted by Harris et al. (2013)) in keeping contact details up to date and remaining willing to 
participate in research are not taken for granted.  They are nurtured through engagement activity and, 
we contend all contribute to this BioResource’s value as a broker of research participants, but also the 
value of each individual asset, a willing research volunteer.  Unlike other conceptions of value in the 
bioeconomy, which focus on the potential of biological fragments and/or database entries, the 
BioResource staff’s labour present BioResource value as best understood as situated in the ongoing 
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biosocial participation of the willing research volunteer.  This value is not fixed, but iteratively produced 
through the accumulation of more volunteers, and, significantly, through the nurturing of the existing 
cohort.  The practices of the BioResource, through an attention to the everyday labour involved in 
running this biobank, present participation and value production as an ongoing practical 
accomplishment.  In doing so, it further highlights the limits of using the concept of clinical labour alone 
to conceptualise biovalue production and the process of participants giving access to their in vitro 
biology.  While this is an important aspect of BioResource participation, the ongoing labour of 
participants and BioResource staff in maintaining involvement are needed to produce value in an 
ongoing way.  The BioResource complicates understandings of the site of (bio)value as the result of 
commodity exchange or the production of knowledge assets.  In the case of the BioResource, value 
resides not only in the biological fragments and associated data held within the database, but most 
significantly in the maintained willingness of these genetically and phenotypically known individuals to 
engage in future research projects. 
As one example of the developing research capacity of the NHS, our study of the BioResource 
and BioResource routine work highlights different ways in which emerging research infrastructures, 
their value as well as citizen participation can be envisaged and understood by actors.  We provide 
insight into this process by focusing on labour and value production.  We have not examined how the 
BioResource translates its value into varying forms of capital by fulfilling its purpose of brokering willing 
research participants.  A focus on the performance of this brokering role would help illuminate how 
value circulates and for whose benefit.  Although important questions for further research, these points 
are beyond the scope of this paper.  Our account does, however, foreground the importance of 
considering the routine labour involved in running a biobank and the role it can play in (bio)value 
production and expand our understanding of the potential sites and scope of (bio)value beyond 
fragments, to include long term biosocial participation of engaged volunteers. 
8 Conclusion 
In this paper we have highlighted how volunteer labour, staff labour and ongoing volunteer 
participation converge in the work of the BioResource and in value production.  Value, in this context, 
is produced not in the laboratory or situated in the partible sample of the individual, but in the 
willingness of the BioResource volunteer to participate in future research.  We demonstrate the 
different ways the value of the BioResource is understood from within the NHS, with management 
focused on the accumulation of biobank entries and BioResource staff working both to increase 
volunteer numbers and maintain the engagement of existing volunteers in this biobanking project.  We 
contend that  BioResource draws into relief the routine labours involved in the value production process.  
Clinical labour and free labour may present certain aspects of this activity, but they fall short of 
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encapsulating the numerous decisions and negotiations that are involved in the everyday work of 
maintaining (the value of) volunteers.  The BioResource presents an example of a biobank where value 
is not fixed or predictable, but iteratively constructed through the ongoing labour of volunteers and 
staff.  In doing so, it questions the limits of existing conceptions of value as commodity or asset and of 
clinical labour as the (sole) means of value production. 
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